» Articles » PMID: 35611358

"PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody": Novel Targeted Nano Ultrasound Contrast Agents for Ultrasound Imaging and Inhibited the Growth of ErbB2-Overexpressing Gastric Cancer Cells

Overview
Specialty Pharmacology
Date 2022 May 25
PMID 35611358
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Gastric cancer is one of the most lethal malignancies in the world. However, the current research on the diagnosis and treatment of nano-ultrasound contrast agents in the field of tumor is mostly focused on breast cancer, ovarian cancer, prostate cancer, liver cancer, etc. Due to the interference of gas in the stomach, there is no report on the treatment of gastric cancer. Herpes simplex virus thymidine kinase/ganciclovir (HSV-TK/GCV) therapy system is the most mature tumor suicide gene in cancer treatment. At the same time, in order to improve its safety and efficiency, we designed a gastric tumor targeted ultrasound-triggered phase-transition nano ultrasound contrast agent PFH/AGM-CBA/HSV-TK/Liposome (PAHL)-Affibody complex.

Methods: In our study, guanidinylated SS-PAAs polymer poly(agmatine/N, N'-cystamine-bis-acrylamide) (AGM-CBA) was used as a nuclear localization vector of suicide gene to form a polyplex, perfluorohexane (PFH) was used as ultrasound contrast agent, liposomes were used to encapsulate perfluorohexane droplets and the polyplexes of AGM-CBA/HSV-TK, and affibody molecules were conjugated to the prepared PAHL in order to obtain a specific targeting affinity to human epidermal growth factor receptor type 2 (ErbB2) at gastric cancer cells. With the aid of ultrasound targeted microbubble destruction technology and the nuclear localization effect of AGM-CBA vector, the transfection efficiency of the suicide gene in gastric cancer cells was significantly increased, leading to significant apoptosis of gastric cancer cells.

Results: It was shown that PAHL-Affibody complex was nearly spherical with an average diameter of 560 ± 28.9 nm, having higher and specific affinity to ErbB2 (+) gastric cells. In vitro experiments further confirmed that PAHL could target gastric cancer cells expressing ErbB2. In a contrast-enhanced ultrasound scanning study, the prepared ultrasound-triggered phase-change nano-ultrasound contrast agent, PAHL, showed improved ultrasound enhancement effects. With the application of the low-frequency ultrasound, the gene transfection efficiency of PAHL was significantly improved,   inducing apoptosis in gastric cancer cells.

Conclusion: This study constructs PFH/AGM-CBA/HSV-TK/Liposome-Affibody nano ultrasound contrast agent, which provides new ideas for the treatment strategy of ErbB2-positive gastric cancer and provides some preliminary experimental basis for its inhibitory effect.

Citing Articles

Recent advances in nanoultrasonography for the diagnosis and treatment of gastrointestinal diseases.

Wan W, Tao H, Chen Z, Guo F, Tian Y Nanomedicine (Lond). 2025; 20(5):519-530.

PMID: 39846205 PMC: 11875487. DOI: 10.1080/17435889.2025.2457319.


Positron emission tomography probes for stem cell monitoring: a review.

Xu L, Shi J, Wu S Am J Transl Res. 2024; 16(8):3534-3544.

PMID: 39262689 PMC: 11384350. DOI: 10.62347/CIUT6327.


HSV: The scout and assault for digestive system tumors.

Li S, Li Q, Ren Y, Yi J, Guo J, Kong X Front Mol Biosci. 2023; 10:1142498.

PMID: 36926680 PMC: 10011716. DOI: 10.3389/fmolb.2023.1142498.


Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities.

Li C, Chang Y, Hsiao M, Chan M Pharmaceutics. 2022; 14(6).

PMID: 35745854 PMC: 9229768. DOI: 10.3390/pharmaceutics14061282.

References
1.
Carion O, Mahler B, Pons T, Dubertret B . Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat Protoc. 2007; 2(10):2383-90. DOI: 10.1038/nprot.2007.351. View

2.
Verma A, Stellacci F . Effect of surface properties on nanoparticle-cell interactions. Small. 2009; 6(1):12-21. DOI: 10.1002/smll.200901158. View

3.
Zhu L, Guo Y, Wang L, Fan X, Xiong X, Fang K . Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs. J Nanobiotechnology. 2017; 15(1):63. PMC: 5622542. DOI: 10.1186/s12951-017-0307-0. View

4.
Jiang N, Chen Q, Cao S, Hu B, Wang Y, Zhou Q . Ultrasound‑targeted microbubbles combined with a peptide nucleic acid binding nuclear localization signal mediate transfection of exogenous genes by improving cytoplasmic and nuclear import. Mol Med Rep. 2017; 16(6):8819-8825. PMC: 5779960. DOI: 10.3892/mmr.2017.7681. View

5.
Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T . Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol. 2007; 34(3):425-34. DOI: 10.1016/j.ultrasmedbio.2007.09.004. View